Please login to the form below

Not currently logged in


This page shows the latest biomarkers news and features for those working in and with pharma, biotech and healthcare.

AZ still sees route to approval for Imfinzi in MYSTIC trial

AZ still sees route to approval for Imfinzi in MYSTIC trial

biomarker also being used by Bristol-Myers Squibb) to make a case for its PD-1 inhibitor Opdivo (nivolumab) after it also failed in first-line NSCLC. ... and BMS is to persuade regulators that the biomarker is valid.

Latest news

More from news
Approximately 4 fully matching, plus 230 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 1 fully matching, plus 32 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 15 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 5 fully matching, plus 12 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company
90TEN Healthcare

90TEN is an award-winning healthcare communications consultancy that puts people at the heart of everything we do. Our Life.Changing. campaigns...

Latest intelligence

Is China ready for a pharmaceutical gold rush?
Some describe doing business in China as akin to the 1990s internet boom – so how stable is its future?...
AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...